BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26475035)

  • 1. No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study.
    Becker C; Jick SS; Meier CR; Bodmer M
    BMC Cancer; 2015 Oct; 15():719. PubMed ID: 26475035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin and the risk of head and neck cancer: a case-control analysis.
    Becker C; Jick SS; Meier CR; Bodmer M
    Diabetes Obes Metab; 2014 Nov; 16(11):1148-54. PubMed ID: 25041125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin and the risk of endometrial cancer: a case-control analysis.
    Becker C; Jick SS; Meier CR; Bodmer M
    Gynecol Oncol; 2013 Jun; 129(3):565-9. PubMed ID: 23523618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis.
    Bodmer M; Becker C; Meier C; Jick SS; Meier CR
    Am J Gastroenterol; 2012 Apr; 107(4):620-6. PubMed ID: 22290402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case-control analysis on metformin and cancer of the esophagus.
    Becker C; Meier CR; Jick SS; Bodmer M
    Cancer Causes Control; 2013 Oct; 24(10):1763-70. PubMed ID: 23820930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin does not alter the risk of lung cancer: a case-control analysis.
    Bodmer M; Becker C; Jick SS; Meier CR
    Lung Cancer; 2012 Nov; 78(2):133-7. PubMed ID: 22959242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis.
    Bodmer M; Becker C; Meier C; Jick SS; Meier CR
    Cancer Epidemiol Biomarkers Prev; 2012 Feb; 21(2):280-6. PubMed ID: 22178569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study.
    Imfeld P; Bodmer M; Jick SS; Meier CR
    J Am Geriatr Soc; 2012 May; 60(5):916-21. PubMed ID: 22458300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: A population based case-control study.
    Brauchli YB; Jick SS; Curtin F; Meier CR
    J Am Acad Dermatol; 2008 Mar; 58(3):421-9. PubMed ID: 18194825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of metformin and the risk of ovarian cancer: a case-control analysis.
    Bodmer M; Becker C; Meier C; Jick SS; Meier CR
    Gynecol Oncol; 2011 Nov; 123(2):200-4. PubMed ID: 21802715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin use and prostate cancer risk.
    Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
    Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin and the risk of renal cell carcinoma: a case-control analysis.
    Becker C; Jick SS; Meier CR; Bodmer M
    Eur J Cancer Prev; 2017 May; 26(3):257-262. PubMed ID: 26945286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes, use of antidiabetic drugs, and the risk of glioma.
    Seliger C; Ricci C; Meier CR; Bodmer M; Jick SS; Bogdahn U; Hau P; Leitzmann MF
    Neuro Oncol; 2016 Mar; 18(3):340-9. PubMed ID: 26093337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin, other antidiabetic drugs, and endometrial cancer risk: a nested case-control study within Italian healthcare utilization databases.
    Franchi M; Asciutto R; Nicotra F; Merlino L; La Vecchia C; Corrao G; Bosetti C
    Eur J Cancer Prev; 2017 May; 26(3):225-231. PubMed ID: 27222938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of antidiabetic medications and risk of chronic obstructive pulmonary disease exacerbation requiring hospitalization: a disease risk score-matched nested case-control study.
    Wang MT; Lai JH; Huang YL; Kuo FC; Wang YH; Tsai CL; Tu MY
    Respir Res; 2020 Dec; 21(1):319. PubMed ID: 33267895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
    Tseng CH
    Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin and other antidiabetic drugs and hepatocellular carcinoma risk: a nested case-control study based on Italian healthcare utilization databases.
    Bosetti C; Franchi M; Nicotra F; Asciutto R; Merlino L; La Vecchia C; Corrao G
    Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):771-8. PubMed ID: 26013675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
    Haring A; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
    Scand J Urol; 2017 Feb; 51(1):5-12. PubMed ID: 28084175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin and the incidence of prostate cancer in patients with type 2 diabetes.
    Azoulay L; Dell'Aniello S; Gagnon B; Pollak M; Suissa S
    Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):337-44. PubMed ID: 21148757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes, use of metformin, and the risk of meningioma.
    Seliger C; Meier CR; Becker C; Jick SS; Proescholdt M; Bogdahn U; Hau P; Leitzmann MF
    PLoS One; 2017; 12(7):e0181089. PubMed ID: 28708856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.